Newron Pharmaceuticals SpA (NWRN)
Market Closed
15 Oct, 03:20 PM
8. 19
CHF +0.23
+2.8894%
295.86M Market Cap
- P/E Ratio
- Div Yield
53,489 Volume
-0.44 Eps
7.96 CHF
Previous Close Want to track NWRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Newron Pharmaceuticals SpA (NWRN) Statistics
Valuation metrics
Market Cap 295.86M
Enterprise value 192.73M
Trailing P/E (ttm) -5.59
Forward P/E 19.65
PEG ratio 0.06
Price/Sales (ttm) 16.3
Price/Book (mrq) -14.28
Enterprise Value/Revenue 18.51
Enterprise Value/EBITDA -8.6
Overview
Shares outstanding 20.01M
Float 17.91M
Shares short -
% Held by insiders 0.13%
% Held by institutions 0.13%
Average volume (10 days) 109.02K
Average volume (90 days) 64.47K
Price summary
52-Week low 5.72
52-Week high 31.85
Beta 0.78
50-Day moving average 10.6
200-Day moving average 12.6
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.83%
Operating margin -2.17%
Operational effectiveness
Return on assets -0.73%
Return on equity 2.58%
Income Statement
Revenue (ttm) 17.49M
Revenue per share (ttm) 0.51
Quarterly revenue growth (yoy) -0.85%
Gross profit (ttm) 17.49M
EBITDA -4.28M
Net income to common (ttm) -12.11M
Diluted EPS (ttm) -1.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 26.41M
Total cash per share (mrq) 1.61
Total debt (mrq) 34.9M
Total Debt/Equity (mrq) -3.34
Current ratio (mrq) 3.15%
Book value per share (mrq) -0.57
Cash Flow
Cash flow statement 29.59M
Levered free cash flow (LFCF) 35.97M
2026 © Marketlog. All Rights Reserved.
